|
WO2007042778A2
|
|
Monitoring cardiovascular disease by determining the expression of kir2ds2 and/or dap12
|
|
US2009286738A1
|
|
Gene Regulation
|
|
GB0608057D0
|
|
Acs therapy
|
|
GB0602838D0
|
|
Sensitivity test
|
|
EP1824995A2
|
|
Diagnosis of prostate cancer
|
|
GB0521524D0
|
|
Diagnosis of prostrate cancer
|
|
GB0520655D0
|
|
Acs thereapy
|
|
GB0510511D0
|
|
Diagnosis of tuberculosis
|
|
WO2005013834A1
|
|
Tamponade balloon assembly
|
|
GB0328080D0
|
|
Electrocardiogram signal processing system
|
|
GB0320592D0
|
|
Muscle phenotyping
|
|
GB0308952D0
|
|
Method
|
|
GB0229151D0
|
|
Product and method
|
|
GB0204909D0
|
|
Improvements in or relating to antimalarial agents
|
|
GB0028122D0
|
|
Method
|
|
GB0022981D0
|
|
Manipulation of spermatozoa
|
|
CA2099869A1
|
|
Particulates
|
